Rodney Young

Rodney Young's Title

Rodney Young currently serves as the Chief Financial Officer (CFO) at RAPT Therapeutics. He joined the company in December 2019, bringing with him a wealth of experience in executive management and corporate finance. As CFO, Rodney is responsible for overseeing the company's financial operations, strategic financial planning, and ensuring fiscal responsibility and transparency. His role is pivotal in driving the company's financial health and supporting its growth objectives.

Rodney Young's Company

Rodney Young is currently associated with RAPT Therapeutics, a biotechnology company focused on developing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Since joining in December 2019, Rodney has leveraged his extensive experience to contribute to the company’s financial strategy and operations. RAPT Therapeutics is known for its innovative approach to drug development, and Rodney's expertise in corporate finance is crucial to its mission of bringing new therapies to market.

Rodney Young's Education and Expertise

Rodney Young holds both an M.B.A. and a B.A. from the University of Chicago. His educational background provides a strong foundation in business administration and finance, which he has built upon with over 30 years of professional experience. Rodney's expertise spans executive management, corporate finance, accounting, financial management, and corporate strategy. His academic credentials, combined with his extensive career, underscore his capability to manage complex financial operations and strategic initiatives in the biotechnology and healthcare sectors.

Rodney Young's Background

Rodney Young has a diverse and extensive background in finance and executive management. Before joining RAPT Therapeutics, he served as the Chief Financial Officer of Cellerant Therapeutics, Inc., where he was instrumental in managing accounting and financial operations and playing a key role in shaping corporate strategy. Prior to that, Rodney held the positions of Chief Financial Officer and Vice President of Finance and Administration at StemCells, Inc. His early career includes significant experience as an investment banker at Lehman Brothers and SG Cowen, where he led financing and merger and acquisition transactions in the healthcare, biotechnology, and pharmaceutical sectors.

Rodney Young's Achievements

Throughout his career, Rodney Young has achieved significant milestones. At Cellerant Therapeutics, he was pivotal in financial management and corporate strategy, contributing to the company's growth and stability. His strategic financial leadership at StemCells, Inc. helped navigate the company through critical phases of its development. As an investment banker, Rodney successfully led numerous financing and M&A transactions, showcasing his ability to drive value and growth in the healthcare and biotech industries. His achievements reflect his deep understanding of financial operations and strategic planning in highly regulated sectors.